Professor Ferdia Gallagher and Dr Mary McLean discuss the use of hyperpolarised carbon-13 magnetic resonance imaging (13C-MRI) in clinical body imaging to probe cancer metabolism. This ground-breaking technique helps to understand how a tumour metabolises sugars to see the effects of chemotherapy and whether treatment has been successful for a patient. The results are available very quickly, in a matter of days, which is game changing in analysing treatment efficacy.
Ferdia is Cancer Research UK Senior Cancer Research Fellow and Professor in Translational Imaging at the University of Cambridge, UK, and is Honorary Consultant Radiologist at Cambridge University Hospitals NHS Foundation Trust.
Mary is a Senior Research Associate at the Cancer Research UK Cambridge Institute, UK.
